Simó M - Search Results

1

Relative roles of bone scintigraphy and positron emission tomography in assessing the treatment response of bone metastases.

García JR, Simó M, Soler M, Pérez G, López S, Lomeña F. García JR, et al. Among authors: simo m. Eur J Nucl Med Mol Imaging. 2005 Oct;32(10):1243-4. doi: 10.1007/s00259-005-1843-7. Eur J Nucl Med Mol Imaging. 2005. PMID: 16133396 No abstract available.

2

99mTc-MDP bone scintigraphy and 18F-FDG positron emission tomography in lung and prostate cancer patients: different affinity between lytic and sclerotic bone metastases.

Garcia JR, Simo M, Perez G, Soler M, Lopez S, Setoain X, Lomeña F. Garcia JR, et al. Among authors: simo m. Eur J Nucl Med Mol Imaging. 2003 Dec;30(12):1714. doi: 10.1007/s00259-003-1370-3. Epub 2003 Nov 19. Eur J Nucl Med Mol Imaging. 2003. PMID: 14625662 No abstract available.

3

[Diagnosis and assessment of therapeutic response of bone metastases by bone scintigraphy and PET study].

García JR, Simó M, Pérez G, Soler M, López S, Setoain X, Castell J, Lomeña F. García JR, et al. Among authors: simo m. Rev Esp Med Nucl. 2004 May-Jun;23(3):197-201. doi: 10.1016/s0212-6982(04)72282-x. Rev Esp Med Nucl. 2004. PMID: 15153364 Spanish.

4

[Positron emission tomography (PET): application in urogenital system oncologic diseases].

Lomeña F, Simó M, Setoain X, Pérez G. Lomeña F, et al. Among authors: simo m. Arch Esp Urol. 2001 Jul-Aug;54(6):649-60. Arch Esp Urol. 2001. PMID: 11512406 Review. Spanish.

5

Usefulness of 18-fluorodeoxyglucose positron emission tomography in the evaluation of tumor cardiac thrombus from renal cell carcinoma.

García JR, Simo M, Huguet M, Ysamat M, Lomeña F. García JR, et al. Among authors: simo m. Clin Transl Oncol. 2006 Feb;8(2):124-8. doi: 10.1007/s12094-006-0169-7. Clin Transl Oncol. 2006. PMID: 16632427

6

[Utility of [18F] FDG PET to differentiate malignancy and benignancy in lung tumours].

Mateos JJ, García JR, Setoain X, Simó M, Soler M, Lomeña F. Mateos JJ, et al. Among authors: simo m. Rev Esp Med Nucl. 2004 Jul-Aug;23(4):287-8. doi: 10.1016/s0212-6982(04)72303-4. Rev Esp Med Nucl. 2004. PMID: 15207217 Spanish. No abstract available.

7

FDG-PET improves the management of patients with suspected recurrence of colorectal cancer.

Simó M, Lomeña F, Setoain J, Pérez G, Castellucci P, Costansa JM, Setoain-Quinquer J, Doménech-Torné F, Carrió I. Simó M, et al. Nucl Med Commun. 2002 Oct;23(10):975-82. doi: 10.1097/00006231-200210000-00007. Nucl Med Commun. 2002. PMID: 12352596 Clinical Trial.

8

[PET assessment of myocardial viability following AMI. Significance of reverse mismatch pattern].

García J, Simó M, Castell J. García J, et al. Among authors: simo m. Rev Esp Cardiol. 2005 Nov;58(11):1364-5. Rev Esp Cardiol. 2005. PMID: 16324593 Free article. Spanish. No abstract available.

9

Fluordeoxyglucose-PET study in first-episode schizophrenic patients during the hallucinatory state, after remission and during linguistic-auditory activation.

Parellada E, Lomena F, Font M, Pareto D, Gutierrez F, Simo M, Fernández-Egea E, Pavia J, Ros D, Bernardo M. Parellada E, et al. Among authors: simo m. Nucl Med Commun. 2008 Oct;29(10):894-900. doi: 10.1097/MNM.0b013e328302cd10. Nucl Med Commun. 2008. PMID: 18769307

10

[Significance of segmentary reversal defects in the myocardial SPECT with 99mTC-tetrofosmin myocardial SPECT].

Romero-Farina G, Candell-Riera J, Aguadé S, Castell J, Soler M, Simó M, Ortega D, Soler-Soler J. Romero-Farina G, et al. Among authors: simo m. Rev Esp Med Nucl. 1999 Oct;18(5):348-55. Rev Esp Med Nucl. 1999. PMID: 10562664 Spanish.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

229 results

Search Page

Filters